Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN
- PMID: 33304897
- PMCID: PMC7693713
- DOI: 10.3389/fcell.2020.553733
Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN
Abstract
Background: Radioresistance is a major challenge in the use of radiotherapy for the treatment of lung cancer while microRNAs (miRs) have been reported to participate in multiple essential cellular processes including radiosensitization. This study was conducted with the main objective of investigating the potential role of miR-320a in radioresistance of non-small cell lung cancer (NSCLC) via the possible mechanism related to HIF1α, KDM5B, and PTEN.
Methods: Firstly, NSCLC radiosensitivity-related microarray dataset GSE112374 was obtained. Then, the expression of miR-320a, HIF1α, KDM5B, and PTEN was detected in the collected clinical NSCLC samples, followed by Pearson's correlation analysis. Subsequently, ChIP assay was conducted to determine the content of the PTEN promoter fragment enriched by the IgG antibody and H3K4me3 antibody. Finally, a series of in vitro and in vivo assays were performed in order to evaluate the effects of miR-320a on radioresistance of NSCLC with the involvement of HIF1α, KDM5B, and PTEN.
Results: The microarray dataset GSE112374 presented with a high expression of miR-320a in NSCLC radiosensitivity samples, which was further confirmed in our clinical samples with the use of reverse transcription-quantitative polymerase chain reaction. Moreover, miR-320a negatively targeted HIF1α, inhibiting radioresistance of NSCLC. Interestingly, miR-320a suppressed the expression of KDM5B, and KDM5B was found to enhance the radioresistance of NSCLC through the downregulation of PTEN expression. The inhibition of miR-320a in radioresistance of NSCLC was also reproduced by in vivo assay.
Conclusion: Taken together, our findings were suggestive of the inhibitory effect of miR-320a on radioresistance of NSCLC through HIF1α-suppression mediated methylation of PTEN.
Keywords: HIF1α; KDM5B; PTEN; microRNA-320a; non-small cell lung cancer; radioresistance.
Copyright © 2020 Xu, Yu, Yuan, Zhang, Ma, Cao, Wang, Zhao and Wang.
Figures







Similar articles
-
Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.Oncotarget. 2016 Aug 2;7(31):49470-49480. doi: 10.18632/oncotarget.9943. Oncotarget. 2016. PMID: 27304056 Free PMC article.
-
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6. Mol Cell Biochem. 2013. PMID: 22956424
-
MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.Oncol Lett. 2017 May;13(5):3247-3252. doi: 10.3892/ol.2017.5863. Epub 2017 Mar 14. Oncol Lett. 2017. PMID: 28521431 Free PMC article.
-
Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis.Exp Cell Res. 2020 Sep 15;394(2):112113. doi: 10.1016/j.yexcr.2020.112113. Epub 2020 May 28. Exp Cell Res. 2020. PMID: 32473223
-
Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.Curr Probl Cancer. 2020 Aug;44(4):100540. doi: 10.1016/j.currproblcancer.2020.100540. Epub 2020 Jan 23. Curr Probl Cancer. 2020. PMID: 32007320 Review.
Cited by
-
Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance.Cancers (Basel). 2022 Sep 20;14(19):4562. doi: 10.3390/cancers14194562. Cancers (Basel). 2022. PMID: 36230484 Free PMC article. Review.
-
E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells.Stem Cells Int. 2022 Sep 20;2022:2760899. doi: 10.1155/2022/2760899. eCollection 2022. Stem Cells Int. 2022. PMID: 36199626 Free PMC article.
-
Overcoming radio-resistance in esophageal squamous cell carcinoma via hypermethylation of PIK3C3 promoter region mediated by KDM5B loss.J Radiat Res. 2022 May 18;63(3):331-341. doi: 10.1093/jrr/rrac004. J Radiat Res. 2022. PMID: 35333349 Free PMC article.
-
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.Front Immunol. 2023 Feb 14;14:1133899. doi: 10.3389/fimmu.2023.1133899. eCollection 2023. Front Immunol. 2023. PMID: 36865554 Free PMC article. Review.
-
Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K/AKT pathway.J Cell Mol Med. 2023 Nov;27(22):3526-3538. doi: 10.1111/jcmm.17933. Epub 2023 Sep 12. J Cell Mol Med. 2023. PMID: 37698037 Free PMC article.
References
-
- Dawe D. E., Christiansen D., Swaminath A., Ellis P. M., Rothney J., Rabbani R., et al. (2016). Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: a systematic review and meta-analysis. Lung. Cancer 99 180–185. 10.1016/j.lungcan.2016.07.016 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials